Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Is Computed Tomography Associated With Survival in Adult Trauma Patients in an Urban Lower-middle Income Setting?

18 febbraio 2020 aggiornato da: Martin Gerdin, Karolinska Institutet
This study is aimed at assessing the survival benefit potentially associated with CT scans for trauma patients in an urban lower-middle income setting.

Panoramica dello studio

Stato

Completato

Condizioni

Descrizione dettagliata

Background

Trauma is defined as an injury caused by an external force to the body. Trauma is one of the major causes of death in the world and accounts for almost five million deaths per year. To quickly and accurately assess damage to internal organs and to be able to identify the potentially fatal injuries, various forms of imaging are used. Examples of such imaging are conventional x-ray scans, Focused Assessment by Sonography in Trauma (FAST), and Computed Tomography (CT). In high-income countries, it has become common to utilize CT as a routine investigation in trauma patients.

The use of whole body CT (WBCT) scans as opposed to selective scanning has been associated with survival benefits for trauma patients, even when the patients undergoing WBCT have more severe injuries than the control group. The studies that investigate this association have been done mostly in high-resource settings where the distance between resuscitation and imaging facilities are short, imaging facilities are more readily available, and the quality of the imaging may be better.

Trauma disproportionally affects low-resource settings. For example, road traffic injuries are responsible for more than 1,3 million deaths per year and of these approximately 90 percent occur in low- and middle-income countries. In low-resource settings the CT may be located far from the resuscitation and surgical resources, and the expertise needed to keep patients stable during the transfer to and from the CT may be limited. Therefore, it is unclear if the survival benefit associated with CT use in high-resource settings also can be observed in low-resource settings.

Aim

To assess if CT within 24 hours of arrival is associated with survival in adult trauma patients in an urban lower-middle income setting.

Study design

The study is a retrospective analysis based on the cohort study Towards Improved Trauma Care Outcomes in India (TITCO).

Setting

The analysis will use the de-identified TITCO cohort, which includes data for a total of 16,000 trauma patients enrolled from four different public university hospitals in urban India. The hospitals are located in Kolkata, Mumbai, and Delhi, and the data was collected between July 2013 and December 2015.

One dedicateds project officer per centre enrolled patients and collected data. The project officer rotated through three shifts: day, evening, and night. The patients who arrived during the shifts when the observer was not present on-site were also enrolled, and the relevant data was retrieved from the patients' case records. The data from patients arriving during the unobserved shifts was consistent with the data from the observed shifts. The patients were followed until either death, discharge, or the length of their hospital stay reached 30 days.

Source and methods of participant selection and follow up

The patients were enrolled and data collected as soon as possible after arrival by the on-site project officer, or if the patient was admitted while the project officer was not present, within the first days of admission. Patients were followed until death or discharge, whichever occurred first.

Variables

Explanatory variable

The main variable investigated will be whether the patient underwent CT within 24 hours of arrival to a participating centre, or not. CT here refers to any type of CT investigation including both WBCT and selective investigations such as scans of the head, thorax, and abdomen.

Other covariates

Covariates will be systolic blood pressure (SBP), heart rate (HR), and Glasgow Coma Scale (GCS), recorded in the emergency department after arrival; as well as sex, age, mechanism of injury, anatomical injury severity quantified using the injury severity score (ISS) and delay between injury and arrival at participating centre.

Data sources

Data on the outcome was extracted from the patients' records, as were the explanatory variable, vital signs, and time data. Data on sex, age, and mechanism of injury was provided by participants or extracted from records. ISS was calculated by a single accredited coder based on injury descriptors extracted from patient records.

Bias

The project officers all held Master's degrees in the health sciences and were trained and supervised continuously throughout the study.

Study size

The estimation of the propensity score is expected to be the most data-intensive part of this study. Because the propensity score will be based on a multivariable model with the explanatory variable as a dichotomous dependent variable the sample size is based on the requirements of such models. Simulation studies show a need for at least ten events, but during some circumstances as much as 20 events, per parameter in the most complex model to achieve reliable coefficient estimates. An event in this case refers to a patient undergoing CT. Counting all covariates, and allowing systolic blood pressure (SBP), heart rate (HR) and age to be non-linearly associated with mortality by non-linear transformations such as restricted cubic splines with three knots, the total number of parameters in the most complex model would be 16. Using 20 events per parameter the required number of events would be 320. Assuming that 20% underwent CT within 24 hours from arrival to participating centre, the minimum required sample size would be 1600 observations.

Quantitative variables

Quantitative variables will be described as continuous. In estimating the propensity score quantitative variables will be treated according to the techniques included in the ensemble library, which may entail dichotomization but also non-linear transformations, for example using splines or fractional polynomials.

Statistical methods

The statistical language R will be used for all analyses. Sample characteristics will be described using medians and inter-quartile ranges (IQR) for quantitative variables and counts and percentages for qualitative variables. To assess if undergoing CT is associated with a survival benefit two analyses will be undertaken. First, the crude absolute risk reduction will be estimated by calculating the difference in mortality between patients undergoing CT and those who did not. Second, a propensity score will be estimated using an ensemble machine learning algorithm such as the Super Learner. The propensity score will be an estimate of the probability that a patient underwent CT, and will be built based on the covariates detailed above. The R package MatchIt, or similar, will then be used to identify pairs of observations that had very similar propensity scores, but that differed in whether the patients underwent CT. The adjusted absolute risk reduction will then be calculated as the difference in mortality between those who underwent CT and those who did not, keeping only paired observations. In formally testing the difference between the two proportions, 95% confidence intervals and a 5% significance level will be used.

Sensitivity analyses

Three sensitivity analyses will be conducted. In the first sensitivity analysis patients who died or were discharged within 24 hours of arrival will be excluded from that analysis to assess whether excluding patients who never had time to reach the CT affect the association. In the second sensitivity analysis patients with a time between injury and arrival to participating hospital that exceeded 24 hours will be excluded. Finally, in the third sensitivity analysis both patients arriving later than 24 hours after injury and patients who died or were discharged within 24 hours after arrival will be excluded.

Strategy to handle missing data

If the sample size requirement is reached if only patients with complete data on the outcome, explanatory variable, and covariates are included then a complete case analysis will be conducted. If the sample size requirement is not reached with a complete case analysis then missing data will be handled employing multiple imputation using chained equations. If so, the number of imputed datasets will be equal to the percentage of incomplete observations. The analyses will be conducted separately in each imputed dataset and the main result reported as the median and IQR across imputations.

Tipo di studio

Osservativo

Iscrizione (Effettivo)

16000

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Delhi
      • New Delhi, Delhi, India, 110029
        • AIIMS Jai Prakash Narayan Apex Trauma Center
    • Maharashtra
      • Mumbai, Maharashtra, India, 400012
        • King Edward Memorial Hospital And Seth Gordhandas Sunderdas Medical College
      • Mumbai, Maharashtra, India, 400022
        • Lokmanya Tilak Municipal General Hospital
    • West Bengal
      • Kolkata, West Bengal, India, 700020
        • Institute of Post-Graduate Medical Education and Research and Seth Sukhlal Karnani Memorial Hospital

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

15 anni e precedenti (Bambino, Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Metodo di campionamento

Campione di probabilità

Popolazione di studio

Adult trauma patients admitted to public university hospitals in urban India

Descrizione

Inclusion Criteria:

  • Presented alive
  • Direct admission
  • ≥ 15 years old

Exclusion Criteria:

  • Burns

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
30 day in hospital mortality
Lasso di tempo: 30 days
Death in hospital within 30 days of arrival to participating centre. Patients who were discharged alive before 30 days were assumed to be alive at 30 days.
30 days

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

15 gennaio 2018

Completamento primario (Effettivo)

31 dicembre 2018

Completamento dello studio (Effettivo)

31 dicembre 2018

Date di iscrizione allo studio

Primo inviato

23 febbraio 2018

Primo inviato che soddisfa i criteri di controllo qualità

23 febbraio 2018

Primo Inserito (Effettivo)

1 marzo 2018

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

20 febbraio 2020

Ultimo aggiornamento inviato che soddisfa i criteri QC

18 febbraio 2020

Ultimo verificato

1 febbraio 2020

Maggiori informazioni

Termini relativi a questo studio

Termini MeSH pertinenti aggiuntivi

Altri numeri di identificazione dello studio

  • tobias-hallden-201802231402

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Cerca prove simili